Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn.
Esophageal motility disorders
Gastroesophageal reflux
Manometry
Journal
Journal of neurogastroenterology and motility
ISSN: 2093-0879
Titre abrégé: J Neurogastroenterol Motil
Pays: Korea (South)
ID NLM: 101530189
Informations de publication
Date de publication:
30 Oct 2021
30 Oct 2021
Historique:
received:
11
06
2020
revised:
30
08
2020
accepted:
16
10
2020
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
14
10
2021
Statut:
ppublish
Résumé
Esophageal motility disorders (EMDs) contribute to the pathophysiology of gastroesophageal reflux disease. However, the causes of EMDs and their impact on gastroesophageal reflux disease-associated symptoms remain unknown. This study aims to elucidate clinical features associated with various types of EMDs in patients with heartburn symptoms. Of the 511 patients who underwent high-resolution manometry, 394 who were evaluated for heartburn symptoms were examined. Patients subjected to high-resolution manometry were classified into 4 groups: outflow obstruction group, hypermotility group, hypomotility group, and normal motility group. Symptoms were evaluated using 3 questionnaires. Patient characteristics and symptoms for each EMD type were compared with those of the normal motility group. Of the 394 patients, 193 (48.9%) were diagnosed with EMDs, including 71 with outflow obstruction, 15 with hypermotility, and 107 with hypomotility. The mean dysphagia score was significantly higher in each of the 3 EMD groups compared with those with normal motility. The mean acid reflux and dyspepsia scores were significantly lower in the outflow obstruction group ( The results of our study indicate that different EMDs have distinct characteristics. Cigarette smoking and high body mass index were associated with esophageal hypermotility. Assessment of the dysphagia symptom scores may help identify patients with EMDs.
Sections du résumé
BACKGROUND/AIMS
OBJECTIVE
Esophageal motility disorders (EMDs) contribute to the pathophysiology of gastroesophageal reflux disease. However, the causes of EMDs and their impact on gastroesophageal reflux disease-associated symptoms remain unknown. This study aims to elucidate clinical features associated with various types of EMDs in patients with heartburn symptoms.
METHODS
METHODS
Of the 511 patients who underwent high-resolution manometry, 394 who were evaluated for heartburn symptoms were examined. Patients subjected to high-resolution manometry were classified into 4 groups: outflow obstruction group, hypermotility group, hypomotility group, and normal motility group. Symptoms were evaluated using 3 questionnaires. Patient characteristics and symptoms for each EMD type were compared with those of the normal motility group.
RESULTS
RESULTS
Of the 394 patients, 193 (48.9%) were diagnosed with EMDs, including 71 with outflow obstruction, 15 with hypermotility, and 107 with hypomotility. The mean dysphagia score was significantly higher in each of the 3 EMD groups compared with those with normal motility. The mean acid reflux and dyspepsia scores were significantly lower in the outflow obstruction group (
CONCLUSIONS
CONCLUSIONS
The results of our study indicate that different EMDs have distinct characteristics. Cigarette smoking and high body mass index were associated with esophageal hypermotility. Assessment of the dysphagia symptom scores may help identify patients with EMDs.
Identifiants
pubmed: 34642275
pii: jnm20131
doi: 10.5056/jnm20131
pmc: PMC8521463
doi:
Types de publication
Journal Article
Langues
eng
Pagination
545-554Références
Am J Gastroenterol. 2006 Aug;101(8):1900-20; quiz 1943
pubmed: 16928254
N Engl J Med. 1971 May 20;284(20):1136-7
pubmed: 5553487
J Clin Gastroenterol. 2007 Feb;41(2):131-7
pubmed: 17245209
J Lab Clin Med. 1989 Oct;114(4):431-8
pubmed: 2794756
Gut. 1988 Nov;29(11):1591-4
pubmed: 3209118
J Gastroenterol. 2018 Jun;53(6):712-717
pubmed: 29075901
World J Gastroenterol. 2013 Oct 14;19(38):6408-15
pubmed: 24151359
Gut. 2005 May;54(5):710-7
pubmed: 15831922
Dig Dis Sci. 1988 Feb;33(2):129-34
pubmed: 3123181
Gut. 2018 Jul;67(7):1351-1362
pubmed: 29437910
Scand J Gastroenterol Suppl. 1996;214:17-20; discussion 21-3
pubmed: 8722400
J Gastroenterol. 2004 Sep;39(9):888-91
pubmed: 15565409
Neurogastroenterol Motil. 2015 Feb;27(2):160-74
pubmed: 25469569
Esophagus. 2020 Jul;17(3):339-347
pubmed: 31982992
Dig Dis Sci. 2011 Mar;56(3):773-6
pubmed: 20676770
Neurogastroenterol Motil. 2011 Jun;23(6):517-e200
pubmed: 21272162
Gut. 1999 Aug;45(2):172-80
pubmed: 10403727
Neurogastroenterol Motil. 2017 Apr;29(4):
pubmed: 27723241
Clin Gastroenterol Hepatol. 2020 Jul;18(8):1719-1726
pubmed: 31442604
Can J Gastroenterol Hepatol. 2014 Jun;28(6):311-4
pubmed: 24945185
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):665-676
pubmed: 28951582
J Gastroenterol Hepatol. 2016 Jun;31(6):1133-40
pubmed: 26670865
Aliment Pharmacol Ther. 1999 Jan;13(1):49-57
pubmed: 9892879
Am J Gastroenterol. 2018 Nov;113(11):1594-1599
pubmed: 30315308
Clin Transl Gastroenterol. 2017 Jun 1;8(6):e94
pubmed: 28569739
Clin Gastroenterol Hepatol. 2007 Dec;5(12):1392-8
pubmed: 17936081
Am J Gastroenterol. 2014 Feb;109(2):171-7
pubmed: 24322837
J Gastroenterol Hepatol. 2004 Sep;19 Suppl 3:S22-5
pubmed: 15324378
Digestion. 2017;95(3):221-228
pubmed: 28343226
Gut. 2006 Oct;55(10):1398-402
pubmed: 16556669
J Gastroenterol. 2016 Aug;51(8):751-67
pubmed: 27325300
Digestion. 2014;89(1):61-7
pubmed: 24458115
Qual Life Res. 2003 Dec;12(8):1003-12
pubmed: 14651418
Gastroenterology. 2018 Jan;154(2):302-318
pubmed: 28827081
Curr Gastroenterol Rep. 2019 Jul 10;21(8):37
pubmed: 31289922
J Neurogastroenterol Motil. 2010 Apr;16(2):120-30
pubmed: 20535342